Literature DB >> 19192150

Antemortem diagnosis of localized central nervous system histiocytic sarcoma in 2 dogs.

L Tzipory1, K M Vernau, B K Sturges, T S Zabka, M A Highland, S A Petersen, E R Wisner, P F Moore, W Vernau.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19192150     DOI: 10.1111/j.1939-1676.2008.0264.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


× No keyword cloud information.
  6 in total

1.  Histiocytic sarcoma with central nervous system involvement in dogs: 19 cases (2006-2012).

Authors:  C L Mariani; M K Jennings; N J Olby; L B Borst; J C Brown; I D Robertson; G S Seiler; E MacKillop
Journal:  J Vet Intern Med       Date:  2015-02-25       Impact factor: 3.333

2.  Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs.

Authors:  Izumi Toyoda; William Vernau; Beverly K Sturges; Karen M Vernau; John Rossmeisl; Kurt Zimmerman; Chelsea M Crowe; Kevin Woolard; Michelle Giuffrida; Robert J Higgins; Peter J Dickinson
Journal:  J Vet Intern Med       Date:  2020-01-10       Impact factor: 3.333

3.  Comparison of the Clinical Characteristics of Histiocytic Sarcoma in Bernese Mountain Dogs and Flat-Coated Retrievers.

Authors:  Suzanne A Erich; Jane M Dobson; Erik Teske
Journal:  Vet Sci       Date:  2022-09-11

Review 4.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

5.  Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.

Authors:  Atigan Thongtharb; Kazuyuki Uchida; James Kenn Chambers; Yumiko Kagawa; Hiroyuki Nakayama
Journal:  J Vet Med Sci       Date:  2015-12-12       Impact factor: 1.267

Review 6.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.